Treatment for deadly superbug C. diff may be weakening
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C.
Yahoo Finance10d
Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion by 2034 at a CAGR Of 6.3% | Fact.MR Report
Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of ...
Mena FN11d
Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion By 2034 At A CAGR Of 6.3% | Fact.MR Report
Fact.MR, in its new offering, presents an unbiased analysis of the Clostridium difficile infection treatment market for 2018 to 2023 and forecast statistics for 2024 to 2034. The study divulges ...